{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:46:18Z","timestamp":1784925978305,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,7,9]],"date-time":"2014-07-09T00:00:00Z","timestamp":1404864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s10067-014-2731-y","type":"journal-article","created":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T03:00:57Z","timestamp":1404788457000},"page":"1239-1246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of golimumab plus methotrexate in methotrexate-na\u00efve patients with severe active rheumatoid arthritis"],"prefix":"10.1007","volume":"33","author":[{"given":"Paul","family":"Emery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy M.","family":"Fleischmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,9]]},"reference":[{"issue":"1","key":"2731_CR1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van\u2019t MA H, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44\u201348","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2731_CR2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/art.21678","volume":"54","author":"JS Smolen","year":"2006","unstructured":"Smolen JS, van der Heijde DM, St Clair EW, Emery P, Bathon JM, Keystone E, Maini RN, Kalden JR, Schiff M, Baker D, Han C, Han J, Bala M (2006) Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum 54(3):702\u2013710","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2731_CR3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.62.2.120","volume":"62","author":"O Meyer","year":"2003","unstructured":"Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A, Nicaise-Roland P, Sibilia J, Combe B (2003) Anticitrullinated protein\/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 62(2):120\u2013126","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2731_CR4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/ard.62.5.427","volume":"62","author":"J Vencovsky","year":"2003","unstructured":"Vencovsky J, Machacek S, Sedova L, Kafkova J, Gatterova J, Pesakova V, Ruzickova S (2003) Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 62(5):427\u2013430","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"2731_CR5","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/art.24638","volume":"60","author":"P Emery","year":"2009","unstructured":"Emery P, Fleischmann RM, Moreland LW, Hsia EC, Strusberg I, Durez P, Nash P, Amante EJ, Churchill M, Park W, Pons-Estel BA, Doyle MK, Visvanathan S, Xu W, Rahman MU (2009) Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis. Arthritis Rheum 60(8):2272\u20132283","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2731_CR6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.21519","volume":"54","author":"FC Breedveld","year":"2006","unstructured":"Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, Sharp J, Perez JL, Spencer-Green GT (2006) The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 54(1):26\u201337","journal-title":"Arthritis Rheum"},{"issue":"9","key":"2731_CR7","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/ard.2010.146043","volume":"70","author":"MU Rahman","year":"2011","unstructured":"Rahman MU, Buchanan J, Doyle MK, Hsia EC, Gathany T, Parasuraman S, Aletaha D, Matteson EL, Conaghan PG, Keystone E, van der Heijde D, Smolen JS (2011) Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16\u00a0years. Ann Rheum Dis 70(9):1631\u20131640","journal-title":"Ann Rheum Dis"},{"key":"2731_CR8","doi-asserted-by":"crossref","unstructured":"Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V, Tugwell P, Weinblatt M, Williams JH, Wolfe F, Kieszak S (1995) American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 38(6):727\u2013735","DOI":"10.1002\/art.1780380602"},{"key":"2731_CR9","doi-asserted-by":"crossref","unstructured":"van Riel PL, van Gestel AM, Scott DL (2000) EULAR Handbook of clinical assessments in rheumatoid arthritis. Van Zuiden Communications, BV, Alphen Aan Den Rijn, The Netherlands","DOI":"10.1136\/ard.59.suppl_1.i28"},{"issue":"2","key":"2731_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","volume":"23","author":"JF Fries","year":"1980","unstructured":"Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23(2):137\u2013145","journal-title":"Arthritis Rheum"},{"issue":"2 Suppl 1","key":"2731_CR11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00019053-200422001-00004","volume":"22","author":"DP Lubeck","year":"2004","unstructured":"Lubeck DP (2004) Patient-reported outcomes and their role in the assessment of rheumatoid arthritis. Pharmacoeconomics 22(2 Suppl 1):27\u201338","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"2731_CR12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.1780350105","volume":"35","author":"DM Heijde van der","year":"1992","unstructured":"van der Heijde DM, van Leeuwen MA, van Riel PL, Koster AM, van\u2019t Hof MA, van Rijswijk MH, van de Putte LB (1992) Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum 35(1):26\u201334","journal-title":"Arthritis Rheum"},{"issue":"5","key":"2731_CR13","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/art.30263","volume":"63","author":"P Emery","year":"2011","unstructured":"Emery P, Fleischmann R, van der Heijde D, Keystone EC, Genovese MC, Conaghan PG, Hsia EC, Xu W, Baratelle A, Beutler A, Rahman MU (2011) The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy. Arthritis Rheum 63(5):1200\u20131210","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2731_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/annrheumdis-2012-201697","volume":"72","author":"CL Wagner","year":"2013","unstructured":"Wagner CL, Visvanathan S, Elashoff M, McInnes IB, Mease PJ, Krueger GG, Murphy FT, Papp K, Gomez-Reino JJ, Mack M, Beutler A, Gladman D, Kavanaugh A (2013) Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab. Ann Rheum Dis 72(1):83\u201388","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2731_CR15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","volume":"64","author":"JA Singh","year":"2012","unstructured":"Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O'Dell J, Winthrop KL, Beukelman T, Bridges SL Jr, Chatham WW, Paulus HE, Suarez-Almazor M, Bombardier C, Dougados M, Khanna D, King CM, Leong AL, Matteson EL, Schousboe JT, Moynihan E, Kolba KS, Jain A, Volkmann ER, Agrawal H, Bae S, Mudano AS, Patkar NM, Saag KG (2012) 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 64(5):625\u2013639","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"2731_CR16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","volume":"73","author":"JS Smolen","year":"2014","unstructured":"Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, de Wit M, Aletaha D, Betteridge N, Bijlsma JW, Boers M, Buttgereit F, Combe B, Cutolo M, Damjanov N, Hazes JM, Kouloumas M, Kvien TK, Mariette X, Pavelka K, van Riel PL, Rubbert-Roth A, Scholte-Voshaar M, Scott DL, Sokka-Isler T, Wong JB, van der Heijde D (2014) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis 73(3):492\u2013509","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl 31","key":"2731_CR17","first-page":"S154","volume":"21","author":"MA Quinn","year":"2003","unstructured":"Quinn MA, Emery P (2003) Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol 21(5 Suppl 31):S154\u2013S157","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"2731_CR18","first-page":"1532","volume":"31","author":"SW Baumgartner","year":"2004","unstructured":"Baumgartner SW, Fleischmann RM, Moreland LW, Schiff MH, Markenson J, Whitmore JB (2004) Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability. J Rheumatol 31(8):1532\u20131537","journal-title":"J Rheumatol"},{"issue":"2","key":"2731_CR19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrrheum.2011.202","volume":"8","author":"S Lillegraven","year":"2012","unstructured":"Lillegraven S, van der Heijde D, Uhlig T, Kvien TK, Haavardsholm EA (2012) What is the clinical relevance of erosions and joint space narrowing in RA? Nat Rev Rheumatol 8(2):117\u2013120","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"2731_CR20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9","volume":"43","author":"JJ Anderson","year":"2000","unstructured":"Anderson JJ, Wells G, Verhoeven AC, Felson DT (2000) Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 43(1):22\u201329","journal-title":"Arthritis Rheum"},{"issue":"11","key":"2731_CR21","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3899\/jrheum.100208","volume":"37","author":"D Heijde van der","year":"2010","unstructured":"van der Heijde D, Breedveld FC, Kavanaugh A, Keystone EC, Landewe R, Patra K, Pangan AL (2010) Disease activity, physical function, and radiographic progression after longterm therapy with adalimumab plus methotrexate: 5-year results of PREMIER. J Rheumatol 37(11):2237\u20132246","journal-title":"J Rheumatol"},{"issue":"12","key":"2731_CR22","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1002\/art.23141","volume":"56","author":"D Heijde van der","year":"2007","unstructured":"van der Heijde D, Klareskog L, Landewe R, Bruyn GA, Cantagrel A, Durez P, Herrero-Beaumont G, Molad Y, Codreanu C, Valentini G, Zahora R, Pedersen R, MacPeek D, Wajdula J, Fatenejad S (2007) Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 56(12):3928\u20133939","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2731_CR23","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/art.20159","volume":"50","author":"RN Maini","year":"2004","unstructured":"Maini RN, Breedveld FC, Kalden JR, Smolen JS, Furst D, Weisman MH, St Clair EW, Keenan GF, van der Heijde D, Marsters PA, Lipsky PE (2004) Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum 50(4):1051\u20131065","journal-title":"Arthritis Rheum"},{"issue":"7","key":"2731_CR24","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/ard.2008.093294","volume":"68","author":"SM Kooij van der","year":"2009","unstructured":"van der Kooij SM, le Cessie S, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Zeben D, Kerstens PJ, Hazes JM, van Schaardenburg D, Breedveld FC, Dijkmans BA, Allaart CF (2009) Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis. Ann Rheum Dis 68(7):1153\u20131158","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2731-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-014-2731-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-014-2731-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T18:08:14Z","timestamp":1746295694000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-014-2731-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["2731"],"URL":"https:\/\/doi.org\/10.1007\/s10067-014-2731-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,9]]}}}